[1]
Väkevä, L. et al. 2015. Intralesional Rituximab Treatment for Primary Cutaneous B-cell Lymphoma: Nine Finnish Cases. Acta Dermato-Venereologica. 96, 3 (Dec. 2015), 396–397. DOI:https://doi.org/10.2340/00015555-2270.